Yousif Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $828K | Buy |
7,282
+270
| +4% | +$30.7K | 0.01% | 1232 |
|
|
2025
Q1 | $737K | Sell |
7,012
-181
| -3% | -$19K | 0.01% | 1265 |
|
|
2024
Q4 | $771K | Buy |
7,193
+96
| +1% | +$10.3K | 0.01% | 1289 |
|
|
2024
Q3 | $710K | Buy |
7,097
+316
| +5% | +$31.6K | 0.01% | 1345 |
|
|
2024
Q2 | $571K | Sell |
6,781
-665
| -9% | -$56K | 0.01% | 1408 |
|
|
2024
Q1 | $544K | Sell |
7,446
-745
| -9% | -$54.5K | 0.01% | 1478 |
|
|
2023
Q4 | $585K | Buy |
8,191
+50
| +0.6% | +$3.57K | 0.01% | 1467 |
|
|
2023
Q3 | $488K | Sell |
8,141
-570
| -7% | -$34.2K | 0.01% | 1496 |
|
|
2023
Q2 | $628K | Sell |
8,711
-357
| -4% | -$25.7K | 0.01% | 1390 |
|
|
2023
Q1 | $667K | Sell |
9,068
-1,245
| -12% | -$91.6K | 0.01% | 1345 |
|
|
2022
Q4 | $689K | Sell |
10,313
-11,605
| -53% | -$775K | 0.01% | 1359 |
|
|
2022
Q3 | $1.18M | Sell |
21,918
-1,308
| -6% | -$70.2K | 0.02% | 1085 |
|
|
2022
Q2 | $1.29M | Sell |
23,226
-2,156
| -8% | -$120K | 0.02% | 1095 |
|
|
2022
Q1 | $1.78M | Buy |
25,382
+361
| +1% | +$25.3K | 0.02% | 1024 |
|
|
2021
Q4 | $2.41M | Buy |
+25,021
| New | +$2.41M | 0.02% | 842 |
|